Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

“…(G) <i>klf2a</i> expression decreases after 15-h lidocaine treatment (90%, <i>n</i> = 67). …”

Decrease of autoantibody levels in highly inflammatory NSG mice. by Henrika Jodeleit (4722312)

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”

Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

“…Downregulation of <i>dom</i> decreased <i>per</i> and <i>tim</i> mRNA levels (middle and right panels), while <i>clk</i> was normal (left panel). …”

PHA decreased pro-inflammatory microglia/macrophages (M1). by Zhenying Han (621634)

Identification of proteins that presented a significant decrease in their expression content. by Rubens D. M. Magalhães (395962)

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

“…Serum and 24-hour stool samples were collected daily. <b><i>Results:</i></b> Mean ± SE serum K decreased (maximum change per corresponding day, 0.6 ± 0.2 mEq/l, p = 0.009) and fecal K increased 58% on patiromer compared with the pretreatment week. …”

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

Increasing and decreasing temperature trends in <i>M</i>. <i>peregrina</i> habitats at 95% confidence level. by Hossein Piri Sahragard (19226096)

“…<p>Increasing and decreasing temperature trends in <i>M</i>. <i>peregrina</i> habitats at 95% confidence level.…”

Decreased FG labeling without RGC loss at prolonged time points. by Yu-Xiang Liang (331856)

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

Targeted point mutation (F639A) in the GluN1 subunit decreases ethanol sensitivity of NMDA receptors. by Carolina R. den Hartog (484817)

Top Genes with Significantly Decreased Transcript Levels at the Site of SSTI¹. by Rebecca A. Brady (408084)

“…<p>¹Top 50 genes with greatest negative change in LFC when comparing infected ears to uninfected ears from challenged mice for each time point represented</p><p>²Function determined via Entrez (<a href="http://www.ncbi.nlm.nih.gov/" target="_blank">www.ncbi.nlm.nih.gov</a>) or Uniprot (<a href="http://www.uniprot.org/" target="_blank">www.uniprot.org</a>)</p><p>³LFC = Log Fold Change</p><p>Italicized values indicate transcripts are significantly increased at the indicated time point.…”

Sphere-forming efficiency decreases following radiation. by Vicky T. Nguyen (5029244)

Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

“…Arrows highlight examples of Tbr2+ cells outside the VZ, while arrowhead point to Tbr2+ cells still in the VZ. Tbr2+ cells have decreased d2EGFP signal in both the VZ and SVZ. …”

Decreased pathology of VLP-treated mice. by Steven B. Bradfute (262649)

DISC1 expression decreases in the course of oligodendrocyte differentiation. by Tsuyoshi Hattori (254566)

Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

“…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”

HvPIN1a localisation is influenced by BFA and its expression is decreased by cytokinin. by Gwendolyn K. Kirschner (5142644)

Molecular and Structural Analysis of Mosaic Variants of Penicillin-Binding Protein 2 Conferring Decreased Susceptibility to Expanded-Spectrum Cephalosporins in <i>Neisseria gonorrh... by Joshua Tomberg (1345956)

“…Transfer of the mosaic <i>penA35</i> allele containing an A501V mutation to FA6140, a chromosomally mediated penicillin-resistant isolate, increased the MICs of ceftriaxone (0.4 μg/mL) and cefixime (1.2 μg/mL) to levels above their respective break points. …”